Introduction
(40-50 mmol Na+/day), frusemide (500 mg/day max) sometimes associated with hydrochlorothiazide One of the consequences of ageing in the general (25 mg) and spironolactone (50 mg), an ACEI and population is the increased frequency of ischaemic digoxin treatment episodically. Fifteen patients (11 and/or hypertensive cardiac failure. Early initiation of men and four women) whose mean age was 66.7 years medical treatment associating healthy and dietary (range. 56-81) were included in the study. The incrimmeasures, digitalo-diuretic treatment and angiotensininated cardiopathy was of ischaemic and/or hypertensconverting enzyme inhibitor (ACEI ) is the rule [1] .
ive origin in eight cases, valvular in three cases and Indeed, ACEI adjunction has improved morbidity and undetermined in four cases. Cardiac failure was isolmortality, as confirmed by the Consensus study where ated in 12 cases, whereas in three cases it was associated mortality figures were found to be 31% with enalapril with end-stage chronic renal failure. One patient had treatment, compared with placebo [2, 3] . However, been treated previously by haemodialysis for 17 years. cardiac insufficiency can be severe and treatmentAccording to the NYHA classification, 11 patients resistant, corresponding to NYHA class IV with poor were in class IV and four were in class III. Chronic prognosis.
hypotension (systolic pressure <100 mm at rest) was Peritoneal dialysis was proposed by Schneierson in noted in five patients, making them bed-ridden. 1949 in a patient under temporary treatment. Sufficient
Medical treatment details are shown in Table 1 . regression of cardiac failure was obtained, followed by
Only one anuric patient previously treated by haemorestored sensitivity of the oedematous syndrome to dialysis did not take diuretics. An ACEI could be used diuretics [4] . Mailloux et al. in 1967 [5] confirmed the only in eight patients because of severe hypotension effectiveness of intermittent peritoneal dialysis in 15 (n=5) or major renal function impairment following patients. Further encouraging results were recorded treatment initiation (n=3). later, both with intermittent peritoneal dialysis and with continuous ambulatory peritoneal dialysis [6] [7] [8] [9] [10] [11] [12] . A recent literature review counted 115 published case Methods reports which gathered patients with congestive heart We used hypertonic (Dianeal Baxter dextrose 3.86%, failure, either isolated or associated with chronic renal 486 osmol/l ) or isotonic (Dianeal Baxter dextrose failure [13].
1.36%, 347 osmol/l ) peritoneal dialysis solutions. A The aim of this study was to assess the effectiveness single-use, disconnectable double bag device was used and tolerance of peritoneal ultrafiltration and to specify in eight patients, and a UV Flash system in six patients. the morbidity linked to cardiac failure, or to the Bags were distributed as follows: one hypertonic bag intercurrent pathology or peritoneal ultrafiltration. every 24 h in seven patients, one hypertonic bag every 48 h in four patients, three isotonic bags per day in one patient and three isotonic+one hypertonic bags prospective, non-randomized study involving patients with cardiac failure refractory to maximal tolerable in two patients. One patient was under automated follow-up. Rapid clinical improvement was noted, within 2-3 weeks following treatment initiation. peritoneal dialysis (intermittent nocturnal peritoneal dialysis) on a cycler for 10-12 h per session.
Patients and methods

Patients
Weight loss was recorded in all patients, from 72.2 kg (range 52-102) to 66.7 kg (range 50-80). Mean Five patients were independent, whereas 10 needed the help of a relative (n=3) or a visiting nurse (n=7). weekly ultrafiltration volume was 3.74 l per patient (range 2.2-6.5). Diuresis (24 h) was stable, from 1.35 (range 0.5-2.5) to 1.48 (range 0.45-3.2) litres in the Parameters studied 14 patients whose diuresis was maintained. Sodium The following parameters were monitored in the course removal was 79 mmol Na+/24 h, including 45 mmol of the study. (i) Duration of patient follow-up and (range 29-92) peritoneally (57%) and 34 mmol (range cause of withdrawal if treatment was stopped; (ii) evo-<10-81) in urine (43%). Echocardiography was perlution of cardiac failure (NYHA class); (iii) body formed in seven patients. The left ventricular ejection weight (kg), diuresis ( l/24 h), weekly peritoneal ultra-fraction was either stable (n=2), improved (n=3) or filtration ( l/week), daily sodium removal (mmol aggravated (n=2). Na+/day); (iv) echocardiography at inclusion and
The breakdown of hospital days is shown in Table  repeated between the third and sixth month of treat-3. The total number of hospitalization days was 241, ment (seven patients); and (v) the frequency and causes including 86 days (36%) due to heart failure, 116 days for hospitalization in relation to peritoneal ultrafiltra-(48%) for intercurrent pathology and 39 days (16%) tion, cardiac failure or intercurrent pathology.
for complications of peritoneal dialysis. Morbidity, expressed as the number of hospitalization days per patient per month, was compared between two periods,
Results
i.e. 6 months before the beginning of peritoneal ultrafiltration and the whole period of follow-up. It Nine of the 15 patients were still undergoing treatment decreased from 3.7 to 1.2 days/patient/month, equivaat the end of follow-up. The mean duration of treat-lent to a 67% decrease in hospitalization time. ment by ultrafiltration or peritoneal dialysis in cases Complications related to the peritoneal dialysis techof end-stage renal failure was 12.7 months (range nique (16%) were peritoneal infection (n=2), abdom-4-28), including eight patients who were or had been inal wall infection (n=1), lack of transient drainage undergoing treatment for >12 months.
(n=3) and catheter displacement requiring its replaceSix patients dropped out during the experimental ment (n=2). period. Withdrawal causes are detailed in Table 2 . Two patients received cardiac transplantation after, respectDiscussion ively, 6 and 15 months of peritoneal ultrafiltration although they previously had been excluded by the surgical team. Four patients died after 4, 10, 11 and Intermittent peritoneal dialysis was prescribed initially in sessions of 24-48 h, using hypertonic glucose solu-12 months, respectively all from heart failure, including one myocardial infarction, one sudden death and two tions during treatment-resistant congestive heart failure in 15 patients [5] . Weight loss of 5.2 kg was achieved heart failures.
Clinically, regression or disappearance of oedema or with 7.2 l of ultrafiltration, and it was followed by restored sensitivity to diuretics in 12 of the 15 patients. even ascitis were associated with an improvement of the cardiac failure class. Out of 10 initially class IV These results were confirmed by two other studies in eight and 10 patients, respectively [6,7]. Raja et al. patients, six became class II and four became class III, and five initially class III were class II at the end of monitored hydric and sodium inflation during eight peritoneal dialysis sessions over 21 months in a patient failure was constant in the literature series (Table 4) . with refractory heart failure. Each session lasted It was generally quick, within 2-4 weeks. It is one of between 48 and 96 h, with an average weight loss of the proven advantages of the peritoneal ultrafiltration 16.9 kg and mean hospitalization time of 18.7 days method. per patient [14] . A reduction in the cardiothoracic index was observed In 1983, continuous ambulatory peritoneal dialysis frequently in 18 of the 19 patients and in seven of the (CAPD) was prescribed in three patients with congest-eight patients in the two studies [11, 15] . ive cardiac failure refractory to a daily dose of 1 g of Haemodynamic analysis is rarely performed, and frusemide. Associating one hypertonic bag with three peritoneal ultrafiltration inconsistently improves the isotonic bags ensured satisfactory control of hydric recorded parameters [11, 16 ] . However, a significant and sodium inflation but aggravated functional renal decrease in mean pulmonary blood pressure was evidfailure and reduced diuresis by 35-80%. Frequent enced in eight patients, from 35 to 20 mmHg without peritonitis required the treatment to be discontinued, any change in cardiac index or echographic data [16 ] . and death occurred within the following 2 weeks. This Our results and those published did not reveal any will constitute a limiting factor to the use of that correlation between functional improvement and that therapeutic strategy [8] . In our experiment, peritoneal of the left ventricular ejection fraction (LVEF ), as infections were very rare because of the very small assessed by echocardiography [9, 11] . Kim et al. number of bag changes during isolated cardiac failure. reported an increase in LVEF from 19 to 34% and More recently, other experiments over longer periods from 24 to 36% in two patients, stability in one patient and involving a greater number of patients have been and deterioration in one patient, although all of them described [12, 13, 15] . Of the 19 patients under long-exhibited functional improvement by one or two classes term follow-up by Konig et al., three had a heart on the NYHA scale [9] . The survival rate of patients transplantation while five were able to suspend CAPD treated by CADP is usually correlated with LVEF at thanks to an improvement of their heart condition the beginning of treatment. It is 90, 79 and 64% at 24 (class II ) and restored sensitivity to diuretics. None of months if LVEF is normal, between 35 and 55% or the deaths (n=8) could be attributed to CAPD-related <35%, respectively [17] . Isotopic evaluation would complications. Stegmayr et al. reported 16 cases includundoubtedly be more accurate [9, 18] . ing seven with concomitant chronic renal failure, five A baseline cardiothoracic index >0.70, the need for of whom had been switched to haemodialysis because ventilation support, the presence of cardiovascular of treatment-resistant congestive heart failure [15] . At collapses and amyloidosis are pejorative prognosis the end of follow-up, seven patients were being treated factors [10,11]. whereas three were able to discontinue CAPD (mean Morbidity, expressed as the number of days of follow-up=10 months in 10 patients) and six died after hospitalization per patient per month, was high and a mean treatment duration of 10.7 months (range unchanged before and after ultrafiltration in earlier 1-24). In our study, only one patient could suspend studies [10, 11] . This has not been confirmed recently, CAPD for 8 months when diuretic treatment became and the frequency of hospitalization decreased from sufficient. At the end of that period, cardiac failure 12.7 to 3.4 for Freida et al. and from 3.7 to 1.2 days recurred, accompanied by severe chronic renal failure.
Improvement of the functional tolerance of cardiac per patient per month according to our own data, 
